Artificial intelligence is emerging as a powerful tool for improving the diagnosis, phenotyping, and treatment of inflammatory skin diseases such as alopecia.

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

Prof. Dr. Bankole Johnson, DSc, MD, Offers Advanced Regenerative Protocols to Support Neurological Wellness and ...

Bhavana (Tina) Bhatnagar, DO, advocates for AI and diverse clinical trials to bridge equity gaps in precision oncology and value-based care.

Survey findings highlight need for improved education and access to precision medicine in the Japanese American ...

In the previous Special Scoop, we introduced the Genomics Laboratory at MedPark Hospital and explored the potential of modern medical genetics. In this edition, let us explore the vital roles that ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for ...

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

Advances in imaging, procedural customization, and artificial intelligence are transforming uterine fibroid embolization into ...

Head of the Regenesys School of Health Sciences, Dr Rowen Govender, argues that the biggest risk is mistaking technology adoption for system improvement ...

QRL-201 shows potential to slow ALS progression by restoring a key protein needed for nerve health, according to data from a Phase 1/2 trial.